{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:00:10Z","timestamp":1788336010207,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":10843,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1990]]},"DOI":"10.1254\/jjp.53.321","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:03:34Z","timestamp":1201151014000},"page":"321-329","source":"Crossref","is-referenced-by-count":47,"title":["Pharmacological Actions of SM-9018, a New Neuroleptic Drug with Both Potent 5-Hydroxytryptamine2 and Dopamine2 Antagonistic Actions"],"prefix":"10.1016","volume":"53","author":[{"given":"Akira","family":"HIROSE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terufumi","family":"KATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"OHNO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"SHIMIZU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"KATSUBE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.53.321_bib1","series-title":"Neuroleptics: Neurochemical, Behavioral and Clinical Perspectives","first-page":"15","article-title":"Neuroleptics and psychiatric disorder","author":"Davis","year":"1983"},{"key":"10.1254\/jjp.53.321_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/ dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1254\/jjp.53.321_bib3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0028-3908(86)90193-0","article-title":"Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat","volume":"25","author":"White","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.53.321_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.ne.03.030180.000323","article-title":"Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs","volume":"3","author":"Baldessarini","year":"1980","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1254\/jjp.53.321_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00428197","article-title":"Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone","volume":"85","author":"Ceulemans","year":"1985","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1254\/jjp.53.321_bib6","first-page":"492","article-title":"Neuroleptic-induced extrapyramidal side effects: clinical perspectives with ritanserin (R 55667), a new selective 5-HT2 receptor blocking agent","volume":"40","author":"Bersani","year":"1986","journal-title":"Curr. Ther. Res."},{"key":"10.1254\/jjp.53.321_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ddr.430080124","article-title":"Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 receptor blocker","volume":"8","author":"Reyntjens","year":"1986","journal-title":"Drug Dev. Res."},{"key":"10.1254\/jjp.53.321_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1254\/jjp.53.321_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00692918","article-title":"3H-TVX Q 7821: identification of 5-HT, binding sites as target for a novel putative anxiolytic","volume":"328","author":"Dompert","year":"1985","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1254\/jjp.53.321_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00172788","article-title":"[3H] Ketanserin labels 5-HT2 receptors and alpha-1 adrenoceptors in human and pig brain membranes","volume":"335","author":"Hoyer","year":"1987","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1254\/jjp.53.321_bib11","first-page":"238","article-title":"Interaction of drugs with apomorphine, tryptamine and norepinephrine, a new \u201cin vivo\u201d approach: the ATN-test in rats","volume":"227","author":"Nlemegeers","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1254\/jjp.53.321_bib12","first-page":"99","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1254\/jjp.53.321_bib13","first-page":"701","article-title":"Pharmacological studies on tlmiperone, a new neuroleptic drug","volume":"31","author":"Yamasaki","year":"1981","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.53.321_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634146","article-title":"Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum","volume":"50","author":"Protais","year":"1976","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1254\/jjp.53.321_bib15","first-page":"324","article-title":"Effects of 3,4-dihydro-1 H-1,4-oxazino (4,3-a) indoles, potential antidepressants, on biogenic amine uptake mechanisms and related activities","volume":"227","author":"Lippmann","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1254\/jjp.53.321_bib16","first-page":"301","article-title":"[3H]Ketanserin (R 41468), a selective 3H-ligand for serotonin2 receptor binding sites","volume":"21","author":"Leysen","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1254\/jjp.53.321_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0028-3908(77)90023-5","article-title":"Neuroleptic drug interactions with norepinephrine alpha-receptor binding sites in rat brain","volume":"16","author":"Peroutka","year":"1977","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.53.321_bib18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/248596a0","article-title":"Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism","volume":"248","author":"Miller","year":"1974","journal-title":"Nature"},{"key":"10.1254\/jjp.53.321_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0028-3908(75)90114-8","article-title":"Serotonergic involvement with neuroleptic catalepsy","volume":"14","author":"Costall","year":"1975","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.53.321_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0091-3057(75)90076-3","article-title":"Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy","volume":"3","author":"Maj","year":"1975","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1254\/jjp.53.321_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00426037","article-title":"Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy","volume":"62","author":"Balsara","year":"1979","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1254\/jjp.53.321_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-2999(85)90135-9","article-title":"Behavioral aspects of serotonin-dopamine interaction in the monkey","volume":"118","author":"Korsgaard","year":"1985","journal-title":"Eur. J. Pharmacol."}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819520054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819520054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:22:44Z","timestamp":1630592564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819520054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990]]}},"alternative-id":["S0021519819520054"],"URL":"https:\/\/doi.org\/10.1254\/jjp.53.321","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1990]]}}}